WGS
GENEDX (WGS) CEO Stueland Sells $1.0M in Stock After Option Exercise
GeneDx chief executive Katherine Stueland exercised 18,750 options and sold 10,501 Class A shares at prices between $94.26 and $99.00 on September 16.
WGS
Market-moving news on GeneDx (NASDAQ: WGS): filings, earnings, deals and other events, from REDFILED.